Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab.
Capuano R, Donnarumma G, Bisecco A, Grimaldi E, Conte M, d'Ambrosio A, Matrone F, Risi M, Borgo RM, Altieri M, Giuliano F, Coppola N, Galdiero M, Tedeschi G, Gallo A.
Capuano R, et al. Among authors: altieri m.
Ther Adv Neurol Disord. 2021 Aug 13;14:17562864211038111. doi: 10.1177/17562864211038111. eCollection 2021.
Ther Adv Neurol Disord. 2021.
PMID: 34413902
Free PMC article.
No abstract available.